Etherna

Pioneering mRNA-LNP platforms for innovative drug delivery solutions

Etherna was founded in 2013, is headquartered in Ghent, Belgium, lists 11–50 employees, and has $103.8M in recorded funding across 3 rounds.

Headquarters
Ghent
Employees
11–50
Founded
2013
Business Model
B2B
Website
etherna.be
Total Funding
$103.8M
Last Round
$39.0M Series BAug 2022
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 9 investors for this company. The full record is or through the API.

About

Etherna (formerly eTheRNA immunotherapies) is a clinical-stage nucleic acid medicine company founded in 2013 as a spin-off of Vrije Universiteit Brussel (VUB), based in Belgium. The company has more than 20 years of combined academic and biotech expertise in mRNA and lipid nanoparticle (LNP) technology, and operates as a technology platform business partnering with pharmaceutical and biotech companies on custom mRNA design, LNP formulation, and GMP-grade RNA production services. Etherna's proprietary delivery platforms enable tailored and innovative solutions for mRNA-based therapeutics, vaccines, and immunotherapies.

Summary

Etherna is a Biotech company based in Ghent, Belgium, founded in 2013. It lists 11–50 employees. It has raised $103.8M in total across 3 rounds, most recently a $39.0M Series B round in Aug 2022. Investors include Kenneth Chien / Novalis LifeSciences, PMV and Marijn Dekkers.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2022
$39.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Etherna on Indexed.vc
<a href="https://indexed.vc/companies/etherna"><img src="https://indexed.vc/api/badge/company/etherna" alt="Etherna on Indexed.vc" width="260" height="76" /></a>